$3.90
00.00%
Pre-Market: 4:01 PM EDT
15 minutes delayed
Comments
Loading...
Omeros (NASDAQ:OMER) Stock Quotes, Forecast and News Summary
Omeros Stock (NASDAQ: OMER) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Omeros (OMER) stock?
You can purchase shares of Omeros (NASDAQ:OMER) through any online brokerage.
Who are Omeros (OMER) competitors?
Other companies in Omeros’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and Xeris Biopharma Holdings (NASDAQ:XERS).
What is the forecast, or price target, for Omeros (OMER) stock?
Omeros has a consensus price target of $5.25.
What is the current price for Omeros (OMER)?
The stock price for Omeros (NASDAQ: OMER) is $3.9 last updated September 24, 2024 at 4:01 PM EDT.
Does Omeros (OMER) pay a dividend?
There are no upcoming dividends for Omeros.
When is Omeros (NASDAQ:OMER) reporting earnings?
Omeros’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Omeros (OMER) going to split?
There is no upcoming split for Omeros.
What sector and industry does Omeros (OMER) operate in?
Omeros is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.